ProQR Therapeutics N.V. Adjustments For Depreciation And Amortisation Expense
ProQR Therapeutics N.V. (PRQR) reported Adjustments For Depreciation And Amortisation Expense of EUR 642.00 thousand for the 3-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2023-11-07
- ProQR Therapeutics N.V. adjustments for depreciation and amortisation expense for the quarter ending 2023-09-30 was 642.00K EUR, a 4.90% increase year-over-year.
- ProQR Therapeutics N.V. adjustments for depreciation and amortisation expense for the quarter ending 2023-06-30 was 594.00K EUR, a 0.51% increase year-over-year.
- ProQR Therapeutics N.V. adjustments for depreciation and amortisation expense for the quarter ending 2023-03-31 was 549.00K EUR, a 3.68% decline year-over-year.
- ProQR Therapeutics N.V. adjustments for depreciation and amortisation expense for the quarter ending 2022-09-30 was 612.00K EUR, a 12.50% increase year-over-year.
| Period end | Adjustments For Depreciation And Amortisation Expense 3 month | Adjustments For Depreciation And Amortisation Expense 6 month | Adjustments For Depreciation And Amortisation Expense 9 month | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | 642.00K EUR 6-K · filed 2023-11-07 | 1.24M EUR derived: sum of 2 quarters · filed 2023-11-07 | 1.78M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 594.00K EUR 6-K · filed 2023-08-03 | 1.14M EUR 6-K · filed 2023-08-03 | ||
| 2023-03-31 | 549.00K EUR 6-K · filed 2023-05-16 | |||
| 2022-09-30 | 612.00K EUR 6-K · filed 2023-11-07 | 1.20M EUR derived: sum of 2 quarters · filed 2023-11-07 | 1.77M EUR 6-K · filed 2023-11-07 | 2.33M EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 591.00K EUR 6-K · filed 2023-08-03 | 1.16M EUR 6-K · filed 2023-08-03 | 1.71M EUR derived: sum of 3 quarters · filed 2023-08-03 | 2.26M EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 570.00K EUR 6-K · filed 2023-05-16 | 1.12M EUR derived: sum of 2 quarters · filed 2023-05-16 | 1.67M EUR derived: sum of 3 quarters · filed 2023-05-16 | 2.27M EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | 552.00K EUR 6-K · filed 2022-02-24 | 1.10M EUR derived: sum of 2 quarters · filed 2022-11-09 | 1.70M EUR derived: sum of 3 quarters · filed 2022-11-09 | 2.33M EUR 20-F · filed 2022-04-29 |
| 2021-09-30 | 544.00K EUR 6-K · filed 2022-11-09 | 1.15M EUR derived: sum of 2 quarters · filed 2022-11-09 | 1.78M EUR 6-K · filed 2022-11-09 | 2.43M EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 602.00K EUR 6-K · filed 2022-08-04 | 1.23M EUR 6-K · filed 2022-08-04 | 1.89M EUR derived: sum of 3 quarters · filed 2022-08-04 | 2.54M EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 631.00K EUR 6-K · filed 2022-05-05 | 1.28M EUR derived: sum of 2 quarters · filed 2022-05-05 | 1.93M EUR derived: sum of 3 quarters · filed 2022-05-05 | 2.46M EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 652.00K EUR 6-K · filed 2022-02-24 | 1.30M EUR derived: sum of 2 quarters · filed 2022-02-24 | 1.83M EUR derived: sum of 3 quarters · filed 2022-02-24 | 2.35M EUR 20-F · filed 2022-04-29 |
| 2020-09-30 | 651.00K EUR 6-K · filed 2021-11-04 | 1.18M EUR derived: sum of 2 quarters · filed 2021-11-04 | 1.70M EUR 6-K · filed 2021-11-04 | 2.21M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 530.00K EUR 6-K · filed 2021-08-05 | 1.05M EUR 6-K · filed 2021-08-05 | 1.56M EUR derived: sum of 3 quarters · filed 2021-08-05 | 2.07M EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 522.00K EUR 6-K · filed 2020-05-07 | 1.03M EUR derived: sum of 2 quarters · filed 2021-02-25 | 1.54M EUR derived: sum of 3 quarters · filed 2021-02-25 | 2.05M EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | 509.00K EUR 6-K · filed 2021-02-25 | 1.01M EUR derived: sum of 2 quarters · filed 2021-02-25 | 1.53M EUR derived: sum of 3 quarters · filed 2021-02-25 | 2.05M EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | 506.00K EUR 6-K · filed 2020-11-16 | 1.02M EUR derived: sum of 2 quarters · filed 2020-11-16 | 1.54M EUR 6-K · filed 2020-11-16 | 1.81M EUR derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | 516.00K EUR 6-K · filed 2020-08-06 | 1.04M EUR 6-K · filed 2020-08-06 | 1.30M EUR derived: sum of 3 quarters · filed 2020-08-06 | 1.55M EUR derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | 521.00K EUR 6-K · filed 2020-05-07 | 788.00K EUR derived: sum of 2 quarters · filed 2020-05-07 | 1.03M EUR derived: sum of 3 quarters · filed 2020-05-07 | 1.27M EUR derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | 267.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | 509.00K EUR derived: sum of 2 quarters · filed 2020-03-31 | 752.00K EUR derived: sum of 3 quarters · filed 2020-03-31 | 992.00K EUR 20-F · filed 2020-03-31 |
| 2018-09-30 | 242.00K EUR 6-K · filed 2019-11-12 | 485.00K EUR derived: sum of 2 quarters · filed 2019-11-12 | 725.00K EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | 243.00K EUR 6-K · filed 2019-08-07 | 483.00K EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | 1.06M EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | 272.00K EUR 6-K · filed 2018-08-08 | 540.00K EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | 1.25M EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | 480.00K EUR 20-F · filed 2018-03-30 |